Transforming the standard of care in multiple disease areas

The premier full-spectrum medicine

Designed with patients and the microbiome in mind, EBX-102 is the superior approach to intestinal microbiota transfer (IMT).

EBX-102 builds on the science and evidence base underpinning IMT through the delivery of complete and viable diverse microbial ecosystems in a patient friendly format.

In contrast to traditional IMT products, EBX-102 is presented in the form of an orally administered capsule that contains colourless, odourless, free flowing powder.

EBX-102 is a standardised and compositionally consistent product manufactured using proprietary manufacturing technology that preserves the microbial ecosystems.

EBX-102 is designed to prevent and treat disease through the restoration and enhancement of gut microbial ecology

Patient friendly

Consists of dried, odourless, colourless powder in an easy to take capsule

Indications

Associated with broad microbiome perturbance and in which proof of principal has been demonstrated through IMT

Dosage

Single dose administered orally, without prior bowel prep

Robust screening

Robust safety screening using state of the art platforms under GMP license

Stable

Stable at a range of temperatures

Proposed Mechanism of Action

Enhances microbiome diversity, reduces ammonia production, improves gut epithelial integrity, reduces systemic inflammation